CT-guided ¹²⁵I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study

1Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. doi: 10.3322/caac.21660 Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A et al Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2021 71 209 49 doi 10.3322/caac.21660Open DOISearch in Google Scholar

2Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 7. doi: 10.1038/s41572-021-00245-6 Hepatocellular carcinoma Nat Rev Dis Primers 2021 7 7 doi 10.1038/s41572-021-00245-6Open DOISearch in Google Scholar

3European Association for the Study of the Liver. Electronic address, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236. doi: 10.1016/j.jhep.2018.03.019 European Association for the Study of the Liver Electronic address, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma J Hepatol 2018 69 182 236 doi 10.1016/j.jhep.2018.03.019Open DOISearch in Google Scholar

4Reig M, Forner A, Rimola J, Ferrer-Fabrega J, Burrel M, Garcia-Criado A, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 2022; 76: 681-93. doi: 10.1016/j.jhep.2021.11.018 Reig M Forner A Rimola J Ferrer-Fabrega J Burrel M Garcia-Criado A et al BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update J Hepatol 2022 76 681 93 doi 10.1016/j.jhep.2021.11.018Open DOISearch in Google Scholar

5Takuma Y, Takabatake H, Morimoto Y, Toshikuni N, Kayahara T, Makino Y, et al. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria. Radiology 2013; 269: 927-37. doi: 10.1148/radiol.13130387 Takuma Y Takabatake H Morimoto Y Toshikuni N Kayahara T Makino Y et al Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria Radiology 2013 269 927 37 doi 10.1148/radiol.13130387Open DOISearch in Google Scholar

6Li W, Ni CF. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma. Abdom Radiol 2019; 44: 2268-75. doi: 10.1007/s00261-019-01943-2 Li W Ni CF Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma Abdom Radiol 2019 44 2268 75 doi 10.1007/s00261-019-01943-2Open DOISearch in Google Scholar

7Peng Z, Chen S, Wei M, Lin M, Jiang C, Mei J, et al. Advanced recurrent hepatocellular carcinoma: treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation. Radiology 2018; 287: 705-14. doi: 10.1148/radiol.2018171541 Peng Z Chen S Wei M Lin M Jiang C Mei J et al Advanced recurrent hepatocellular carcinoma: treatment with sorafenib alone or in combination with transarterial chemoembolization and radiofrequency ablation Radiology 2018 287 705 14 doi 10.1148/radiol.2018171541Open DOISearch in Google Scholar

8Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012; 262: 689-700. doi: 10.1148/radiol.11110637 Peng ZW Zhang YJ Liang HH Lin XJ Guo RP Chen MS Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial Radiology 2012 262 689 700 doi 10.1148/radiol.11110637Open DOISearch in Google Scholar

9Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-51. PMID: 11002219 Seki T Tamai T Nakagawa T Imamura M Nishimura A Yamashiki N et al Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma Cancer 2000 89 1245 51 PMID: 11002219Search in Google Scholar

10Li Z, Jiao D, Han X, Si G, Li Y, Liu J, et al. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Cancer Imaging 2020; 20: 13. doi: 10.1186/s40644-020-0294-5 Li Z Jiao D Han X Si G Li Y Liu J et al Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma Cancer Imaging 2020 20 13 doi 10.1186/s40644-020-0294-5Open DOISearch in Google Scholar

11Zaitoun MMA, Elsayed SB, Zaitoun NA, Soliman RK, Elmokadem AH, Farag AA, et al. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm. Int J Hyperthermia 2021; 38: 248-56. doi: 10.1080/02656736.2021.1887941 Zaitoun MMA Elsayed SB Zaitoun NA Soliman RK Elmokadem AH Farag AA et al Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm Int J Hyperthermia 2021 38 248 56 doi 10.1080/02656736.2021.1887941Open DOISearch in Google Scholar

12Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, et al. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma. Int J Hyperthermia 2011; 27: 654-62. doi: 10.3109/02656736.2011.605099 Liu C Liang P Liu F Wang Y Li X Han Z et al MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma Int J Hyperthermia 2011 27 654 62 doi 10.3109/02656736.2011.605099Open DOISearch in Google Scholar

13Shi F, Wu M, Lian SS, Mo ZQ, Gou Q, Xu RD, et al. Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: Long-term outcomes. Radiology 2019; 293: 707-15. doi: 10.1148/radiol.2019181991 Shi F Wu M Lian SS Mo ZQ Gou Q Xu RD et al Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization: Long-term outcomes Radiology 2019 293 707 15 doi 10.1148/radiol.2019181991Open DOISearch in Google Scholar

14Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-32. doi: 10.1200/JCO.2012.42.9936 Peng ZW Zhang YJ Chen MS Xu L Liang HH Lin XJ et al Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial J Clin Oncol 2013 31 426 32 doi 10.1200/JCO.2012.42.9936Open DOISearch in Google Scholar

15Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 2016; 32: 339-44. doi: 10.3109/02656736.2015.1127434 Facciorusso A Di Maso M Muscatiello N Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis Int J Hyperthermia 2016 32 339 44 doi 10.3109/02656736.2015.1127434Open DOISearch in Google Scholar

16Llovet JM, De Baere T, Kulik L, Haber PK, Greten TF, Meyer T, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021; 18: 293-313. doi: 10.1038/s41575-020-00395-0 Llovet JM De Baere T Kulik L Haber PK Greten TF Meyer T et al Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma Nat Rev Gastroenterol Hepatol 2021 18 293-313 doi 10.1038/s41575-020-00395-0Open DOISearch in Google Scholar

17Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002; 178: 47-51. doi: 10.2214/ajr.178.1.1780047 Lu DS Raman SS Vodopich DJ Wang M Sayre J Lassman C Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect AJR Am J Roentgenol 2002 178 47 51 doi 10.2214/ajr.178.1.1780047Open DOISearch in Google Scholar

18Zheng H, Liu K, Yang Y, Liu B, Zhao X, Chen Y, et al. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study. Eur Radiol 2022. 32: 4657-66. doi: 10.1007/s00330-022-08537-5 Zheng H Liu K Yang Y Liu B Zhao X Chen Y et al Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study Eur Radiol 2022 32 4657 66 doi 10.1007/s00330-022-08537-5Open DOISearch in Google Scholar

19An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, et al. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. Eur Radiol 2021; 31: 4764-73. doi: 10.1007/s00330-020-07571-5 An C Li WZ Huang ZM Yu XL Han YZ Liu FY et al Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis Eur Radiol 2021 31 4764 73 doi 10.1007/s00330-020-07571-5Open DOISearch in Google Scholar

20Li Q, Ao GK, Duan F, Wang ZJ, Yan JY, Wang MQ. Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: experience from 182 patients with survival time more than 3 years. Eur J Radiol 2015; 84: 2555-63. doi: 10.1016/j.ejrad.2015.10.006 Li Q Ao GK Duan F Wang ZJ Yan JY Wang MQ Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: experience from 182 patients with survival time more than 3 years Eur J Radiol 2015 84 2555 63 doi 10.1016/j.ejrad.2015.10.006Open DOISearch in Google Scholar

21Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999; 17: 517-22. doi: 10.1200/jco.1999.17.2.517 Zelefsky MJ Wallner KE Ling CC Raben A Hollister T Wolfe T et al Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer J Clin Oncol 1999 17 517 22 doi 10.1200/jco.1999.17.2.517Open DOISearch in Google Scholar

22Chen K, Chen G, Wang H, Li H, Xiao J, Duan X, et al. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial. J Hepatol 2014; 61: 1304-11. doi: 10.1016/j.jhep.2014.07.026 Chen K Chen G Wang H Li H Xiao J Duan X et al Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial J Hepatol 2014 61 1304 11 doi 10.1016/j.jhep.2014.07.026Open DOISearch in Google Scholar

23Wang G, Zhang F, Yang B, Xue J, Peng S, Zhong Z, et al. Feasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinoma. Radiology 2016; 278: 897-905. doi: 10.1148/radiol.2015150641 Wang G Zhang F Yang B Xue J Peng S Zhong Z et al Feasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinoma Radiology 2016 278 897 905 doi 10.1148/radiol.2015150641Open DOISearch in Google Scholar

24Ruge MI, Simon T, Suchorska B, Lehrke R, Hamisch C, Koerber F, et al. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome. J Clin Oncol 2011; 29: 4151-9. doi: 10.1200/JCO.2011.37.3381 Ruge MI Simon T Suchorska B Lehrke R Hamisch C Koerber F et al Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome J Clin Oncol 2011 29 4151 9 doi 10.1200/JCO.2011.37.3381Open DOISearch in Google Scholar

25Ren Y, Dong X, Chen L, Sun T, Alwalid O, Kan X, et al. Combined ultrasound and CT-guided Iodine-125 seeds implantation for treatment of residual hepatocellular carcinoma located at complex sites after transcatheter arterial chemoembolization. Front Oncol 2021; 11: 582544. doi: 10.3389/fonc.2021.582544 Ren Y Dong X Chen L Sun T Alwalid O Kan X et al Combined ultrasound and CT-guided Iodine-125 seeds implantation for treatment of residual hepatocellular carcinoma located at complex sites after transcatheter arterial chemoembolization Front Oncol 2021 11 582544 doi 10.3389/fonc.2021.582544Open DOISearch in Google Scholar

26Lin ZY, Chen J, Deng XF. Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. Eur J Radiol 2012; 81: 3079-83. doi: 10.1016/j.ejrad.2012.05.007 Lin ZY Chen J Deng XF Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation Eur J Radiol 2012 81 3079 83 doi 10.1016/j.ejrad.2012.05.007Open DOISearch in Google Scholar

27Gao FL, Wang Y, Huang XZ, Pan TF, Guo JH. I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma. BMC Gastroenterol 2022; 22: 273. doi: 10.1186/s12876-022-02356-0 Gao FL Wang Y Huang XZ Pan TF Guo JH I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma BMC Gastroenterol 2022 22 273 doi 10.1186/s12876-022-02356-0Open DOISearch in Google Scholar

28Wang W, Wang C, Shen J, Ren B, Yin Y, Yang J, et al. Integrated I-125 seed implantation combined with transarterial chemoembolization for treatment of hepatocellular carcinoma with main portal vein tumor thrombus. Cardiovasc Intervent Radiol 2021; 44: 1570-8. doi: 10.1007/s00270-021-02887-1 Wang W Wang C Shen J Ren B Yin Y Yang J et al Integrated I-125 seed implantation combined with transarterial chemoembolization for treatment of hepatocellular carcinoma with main portal vein tumor thrombus Cardiovasc Intervent Radiol 2021 44 1570 8 doi 10.1007/s00270-021-02887-1Open DOISearch in Google Scholar

29Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 2009; 29: 661-77. doi: 10.1177/0272989x09341755 Austin PC The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies Med Decis Making 2009 29 661 77 doi 10.1177/0272989x09341755Open DOISearch in Google Scholar

30Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358-80. doi: 10.1002/hep.29086 Heimbach JK Kulik LM Finn RS Sirlin CB Abecassis MM Roberts LR et al AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology 2018 67 358 80 doi 10.1002/hep.29086Open DOISearch in Google Scholar

31Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43: 1101-8. doi: 10.1002/hep.21164 Teratani T Yoshida H Shiina S Obi S Sato S Tateishi R et al Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations Hepatology 2006 43 1101 8 doi 10.1002/hep.21164Open DOISearch in Google Scholar

32Lin JW, Lin CC, Chen WT, Lin SM. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations. Kaohsiung J Med Sci 2014; 30: 396-401. doi: 10.1016/j.kjms.2014.04.006 Lin JW Lin CC Chen WT Lin SM Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations Kaohsiung J Med Sci 2014 30 396 401 doi 10.1016/j.kjms.2014.04.006Open DOISearch in Google Scholar

33Llovet JM, Lencioni R. mRECIST for HCC: Performance and novel refinements. J Hepatol 2020; 72: 288-306. doi: 10.1016/j.jhep.2019.09.026 Llovet JM Lencioni R mRECIST for HCC: Performance and novel refinements J Hepatol 2020 72 288 306 doi 10.1016/j.jhep.2019.09.026Open DOISearch in Google Scholar

34Hong D, Zhou Y, Wan X, Su H, Shao H. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer 2021; 21: 1020. doi: 10.1186/s12885-021-08680-0 Hong D Zhou Y Wan X Su H Shao H Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma BMC Cancer 2021 21 1020 doi 10.1186/s12885-021-08680-0Open DOISearch in Google Scholar

35Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29: iv238-iv55. doi: 10.1093/annonc/mdy308 Vogel A Cervantes A Chau I Daniele B Llovet JM Meyer T et al Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 2018 29 iv238 iv55 doi 10.1093/annonc/mdy308Open DOISearch in Google Scholar

36Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, et al. Tumor location influences oncologic outcomes of hepatocellular carcinoma patients undergoing radiofrequency ablation. Cancers 2018; 10. 501. doi: 10.3390/cancers10100378 Chen J Peng K Hu D Shen J Zhou Z Xu L et al Tumor location influences oncologic outcomes of hepatocellular carcinoma patients undergoing radiofrequency ablation Cancers 2018 10 501 doi 10.3390/cancers10100378Open DOISearch in Google Scholar

37Zhang TQ, Huang ZM, Shen JX, Chen GQ, Shen LJ, Ai F, et al. Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma. Therap Adv Gastroenterol 2019; 12: 1756284819862966. doi: 10.1177/1756284819862966 Zhang TQ Huang ZM Shen JX Chen GQ Shen LJ Ai F et al Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma Therap Adv Gastroenterol 2019 12 1756284819862966 doi 10.1177/1756284819862966Open DOISearch in Google Scholar

38DeWeese TL, Shipman JM, Dillehay LE, Nelson WG. Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 1998; 159: 591-8. doi: 10.1016/s0022-5347(01)63990-9 DeWeese TL Shipman JM Dillehay LE Nelson WG Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure J Urol 1998 159 591 8 doi 10.1016/s0022-5347(01)63990-9Open DOISearch in Google Scholar

39Koritzinsky M, Wouters BG, Amellem O, Pettersen EO. Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation. Int J Radiat Biol 2001; 77: 319-28. doi: 10.1080/09553000010019278 Koritzinsky M Wouters BG Amellem O Pettersen EO Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation Int J Radiat Biol 2001 77 319 28 doi 10.1080/09553000010019278Open DOISearch in Google Scholar

40Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17: 1117-24. doi: 10.1097/01.Rvi.0000228373.58498.6e Grieco CA Simon CJ Mayo-Smith WW DiPetrillo TA Ready NE Dupuy DE Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer J Vasc Interv Radiol 2006 17 1117 24 doi 10.1097/01.Rvi.0000228373.58498.6eOpen DOISearch in Google Scholar

41Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes. Radiology 2014; 270: 888-99. doi: 10.1148/radiol.13130753 Kang TW Lim HK Lee MW Kim YS Choi D Rhim H Perivascular versus nonperivascular small HCC treated with percutaneous RF ablation: retrospective comparison of long-term therapeutic outcomes Radiology 2014 270 888 99 doi 10.1148/radiol.13130753Open DOISearch in Google Scholar

42Kang TW, Lim HK, Lee MW, Kim YS, Rhim H, Lee WJ, et al. Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus non-subcapsular hepatocellular carcinoma: a propensity score matched study. Radiology 2016; 280: 300-12. doi: 10.1148/radiol.2016151243 Kang TW Lim HK Lee MW Kim YS Rhim H Lee WJ et al Long-term therapeutic outcomes of radiofrequency ablation for subcapsular versus non-subcapsular hepatocellular carcinoma: a propensity score matched study Radiology 2016 280 300 12 doi 10.1148/radiol.2016151243Open DOISearch in Google Scholar

43Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol 2009; 10: 718-26. doi: 10.1016/s1470-2045(09)70082-8 Formenti SC Demaria S Systemic effects of local radiotherapy Lancet Oncol 2009 10 718 26 doi 10.1016/s1470-2045(09)70082-8Open DOISearch in Google Scholar

44De Palma M, Coukos G, Hanahan D. A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy. Cancer Cell 2013; 24: 559-61. doi: 10.1016/j.ccr.2013.10.019 De Palma M Coukos G Hanahan D A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy Cancer Cell 2013 24 559 61 doi 10.1016/j.ccr.2013.10.019Open DOISearch in Google Scholar

45Hu HT, Luo JP, Cao GS, Li Z, Jiang M, Guo CY, et al. Hepatocellular carcinoma with portal vein tumor thrombus treated with transarterial chemoembolization and sorafenib vs. (125)Iodine implantation. Front Oncol 2021; 11: 806907. doi: 10.3389/fonc.2021.806907 Hu HT Luo JP Cao GS Li Z Jiang M Guo CY et al Hepatocellular carcinoma with portal vein tumor thrombus treated with transarterial chemoembolization and sorafenib vs. (125)Iodine implantation Front Oncol 2021 11 806907 doi 10.3389/fonc.2021.806907Open DOISearch in Google Scholar

46Yang M, Fang Z, Yan Z, Luo J, Liu L, Zhang W, et al. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial. J Cancer Res Clin Oncol 2014; 140: 211-9. doi: 10.1007/s00432-013-1568-0 Yang M Fang Z Yan Z Luo J Liu L Zhang W et al Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial J Cancer Res Clin Oncol 2014 140 211 9 doi 10.1007/s00432-013-1568-0Open DOISearch in Google Scholar

47Lee J, Shin IS, Yoon WS, Koom WS, Rim CH. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol 2020; 145: 63-70. doi: 10.1016/j.radonc.2019.12.004 Lee J Shin IS Yoon WS Koom WS Rim CH Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review Radiother Oncol 2020 145 63 70 doi 10.1016/j.radonc.2019.12.004Open DOISearch in Google Scholar